Results 41 to 50 of about 8,882 (195)

Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis

PLoS ONE, 2022
Objective To systematically evaluate the prognostic factors for mortality in bullous pemphigoid. Methods PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, China Biology Medicine disc and Wanfang Database were searched to collect ...
Xianxia Chen, Yaqiang Zhang, Zhicheng Luo, Yujuan Wu, Taoxiang Niu, Jiayuan Zheng, Yuanyuan Xie   +6 more
doaj   +2 more sources

Clinical Relevance of Autoantibodies in Patients with Autoimmune Bullous Dermatosis

Clinical and Developmental Immunology, 2012
The authors present their experience related to the diagnosis, treatment, and followup of 431 patients with bullous pemphigoid, 14 patients with juvenile bullous pemphigoid, and 273 patients with pemphigus.
Lilla Mihályi, Mária Kiss, Attila Dobozy, Lajos Kemény, Sándor Husz   +4 more
doaj   +1 more source

Pemphigoid gestationis and intravenous immunoglobulin therapy

International Journal of Women's Dermatology, 2018
Pemphigoid gestationis, which is also known as herpes gestationis, is a rare, pregnancy-associated, autoimmune bullous disease. Treatment depends on the severity of the disease for each patient and the safety and use of these drugs during pregnancy and ...
Anes Yang, MD, BMed, MPH, Elizabeth Uhlenhake, MD, FAAD, Dedee F. Murrell, MA, BMBCh, FAAD, MD, FACD, FRCP   +2 more
doaj   +1 more source

Bullous pemphigoid and autoimmunity

Journal of the American Academy of Dermatology, 1993
There are many case reports of bullous pemphigoid (BP) in association with a variety of autoimmune disorders, but no large case controlled studies have been performed.Our purpose was to determine whether there is an increased incidence of autoimmune disorders in patients with BP and whether there is a particular haplotype associated with this.A total ...
Taylor, G, Venning, V, Wojnarowska, F, Welch, K   +3 more
openaire   +3 more sources

Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis

JPGN Reports, EarlyView.
Abstract We describe a pediatric patient treated with upadacitinib for atopic dermatitis (AD) who subsequently achieved sustained clinical and histologic remission of eosinophilic esophagitis (EoE). Upadacitinib is an oral small molecule selective Janus kinase 1 inhibitor that inhibits janus kinase‐signal transduction and activation of transcription ...
Nathalie Nguyen, Maureen Bauer
wiley   +1 more source

Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis Bullosa

JEADV Clinical Practice, Volume 5, Issue 2, Page 648-650, June 2026.
ABSTRACT Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions. Herein, we report a case of intermediate junctional epidermolysis bullosa that improved significantly with oral 4,4’‐diamino‐diphenyl ...
Shiho Mori, Manabu Fujimoto, Katsuto Tamai   +2 more
wiley   +1 more source

Bullous pemphigoid in infancy. [PDF]

J Dtsch Dermatol Ges
Ehrenreich J, Golle L, Lange T, Schmidt E, Kreft B.   +4 more
europepmc   +6 more sources

A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis

Journal of Dermatological Treatment
Aim: Bullous pemphigoid induced by secukinumab in treatment of psoriasis is rare.Methods: We report a 49-year-old man with psoriasis who developed bullous pemphigoid during treatment with secukinumab.Results: Scattered tense vesicles with itching ...
Guanghan Wang, Xiaojing Hu, Shixin Han, Meijuan Zhou   +3 more
doaj   +1 more source

Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients [PDF]

Anais Brasileiros de Dermatologia, 2014
BACKGROUND: aAlthough rare, bullous pemphigoid (BP) is the most common autoimmune blistering disease. Recent studies have shown that patients with bullous pemphigoid are more likely to have neurological and psychiatric diseases, particularly prior to the
Vera Barreto Teixeira, Rita Cabral, Maria Manuel Brites, Ricardo Vieira, Américo Figueiredo   +4 more
doaj   +1 more source

Buccal Mucosa as Substrate for Direct Immunofluorescence Should Be Included Early in the Diagnostic Work Up of Ocular Mucous Membrane Pemphigoid

JEADV Clinical Practice, Volume 5, Issue 2, Page 597-601, June 2026.
ABSTRACT Background In ocular mucous membrane pemphigoid (MMP) direct immunofluorescence (DIF) represents the gold standard for definitive diagnosis. However, up to 50% of ocular MMP cases do not meet the immunopathological criteria. In addition, the risk of exacerbating conjunctival cicatrization makes ocular biopsy technically difficult to obtain ...
Andrea Gabusi, Michelangelo La Placa, Davide Bartolomeo Gissi, Federica Filippi, Camilla Loi, Cosimo Misciali, Federico Bardazzi   +6 more
wiley   +1 more source